Mental Health Clinics in Ocean Gate, NJ Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Continuing Bonds Therapy, Llc Clinic - Adult Mental Health Medicare: Medicare Enrolled Practice Location: 21 W Point Pleasant Ave, Ocean Gate, NJ 08740 Phone: 732-614-1062 |
News Archive
Soligenix, Emergent BioSolutions sign development agreement
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for the RiVax drug substance protein antigen.
Seropositivity to SARS-CoV-2 among asymptomatic blood donors in New York
New York was the hardest-hit U.S. state during the peak of the outbreak in the country. Now, a team of researchers from the New York Blood Center and Serimmune, an immune intelligence company, aimed to determine the prevalence of seropositive people for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, among healthy blood donors.
Bacteria can barge inside immune cells
Immune cells that are the body's front-line defense don't necessarily rest quietly until invading bacteria lock onto receptors on their outside skins and rouse them to action, as previously thought. In a new paper, University of Michigan scientists describe their findings that bacteria can barge inside these guard cells and independently initiate a powerful immune response.
Biodel selects BIOD-105, BIOD-107 recombinant human insulin formulations for clinical testing, development
Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.
New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome
Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.
› Verified 2 days ago